AIEQ · Exit · 1d
weight 0.050% → 0 (exited)·stock down 6.4% in the 30 days before
Sep 1·entry $172.30·now $176.52
+2.45%
since Sep 1
GL
GrowthGLOBE LIFE INC.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products.
Close · 3M
+16.71%
Held by 0 AI ETFs
None of the tracked AI ETFs currently hold this name.
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals1
Win rate0% (0/1)
Avg buy return-4.11%
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Passes the frameworkas of Aug 2
The AI ETF AIEQ has recently initiated a new position in Globe Life, indicating its algorithm views the company favorably. This action aligns with the value-investing framework's 'Pass' verdict, suggesting a shared positive outlook on GL's investment potential. Both approaches seem to identify the company as an attractive holding at its current valuation.
- Circle of CompetenceThe life and health insurance industry's reliance on actuarial predictability and long-term policy contracts allows for reasonable projection of unit economics and cash flows.
- Economic MoatEstablished insurance companies like Globe Life benefit from significant brand recognition, regulatory barriers to entry, and the inherent switching costs associated with long-term policy relationships.
- ManagementInformation on management's candor, capital allocation track record, and ownership stake is not available from the provided financial snapshot.
- Financial HealthThe reported ROE of 20.33% indicates strong profitability and efficient use of equity capital, supporting a conclusion of robust financial health.
- Margin of SafetyThe Price-to-Earnings ratio of 11.11, combined with a strong ROE of 20.33%, suggests the stock may trade at a defensible discount to its intrinsic value.
Globe Life appears to be a company operating within the circle of competence, possessing an identifiable economic moat in the insurance sector. Its financial health is strong, as evidenced by a high return on equity, and the current valuation suggests a potential margin of safety. While management's capital allocation and candor could not be fully assessed from the provided data, the overall picture points to a sound investment.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.